VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+6.27%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$96.7B
AUM Growth
+$96.7B
(-4.8%)
Cap. Flow
-$6.78B
Cap. Flow
% of AUM
-7.01%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
2,900
New
61
Increased
770
Reduced
1,800
Closed
67
Top Buys
| 1 |
Broadcom
AVGO
|
$1.6B |
| 2 |
UnitedHealth
UNH
|
$375M |
| 3 |
JPMorgan Chase
JPM
|
$301M |
| 4 |
PayPal
PYPL
|
$281M |
| 5 |
Intuitive Surgical
ISRG
|
$244M |
Top Sells
| 1 |
Apple
AAPL
|
$911M |
| 2 |
Amazon
AMZN
|
$823M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$659M |
| 4 |
Microsoft
MSFT
|
$598M |
| 5 |
ASML
ASML
|
$367M |
Sector Composition
| 1 | Technology | 31.93% |
| 2 | Healthcare | 9.84% |
| 3 | Consumer Discretionary | 8.9% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
2576
DELISTED
2seventy bio
TSVT
| $77.9K | ﹤0.01% | 16,510 -124 | -0.7% | -$585 |
|
2577
Fulcrum Therapeutics
FULC
$351M
| $77.4K | ﹤0.01% | 21,671 +517 | +2% | +$1.85K |
|
|
BHR
2578
Braemar Hotels & Resorts
BHR
$188M
| $77.2K | ﹤0.01% | 24,993 +31 | +0.1% | +$96 |
|
2579
James River Group
JRVR
$258M
| $76.7K | ﹤0.01% | 12,235 -369 | -3% | -$2.31K |
|
2580
Lyell Immunopharma
LYEL
$213M
| $76.6K | ﹤0.01% | 55,539 -3,046 | -5% | -$4.2K |
|
2581
LanzaTech
LNZA
$49.1M
| $76.1K | ﹤0.01% | 39,851 | – | – |
|
2582
Omeros
OMER
$283M
| $75.5K | ﹤0.01% | 19,016 -443 | -2% | -$1.76K |
|
2583
Prime Medicine
PRME
$578M
| $74.2K | ﹤0.01% | 19,184 | – | – |
|
2584
Trevi Therapeutics
TRVI
$883M
| $74.2K | ﹤0.01% | 22,222 -212 | -0.9% | -$708 |
|
2585
Sight Sciences
SGHT
$213M
| $74K | ﹤0.01% | 11,742 -366 | -3% | -$2.31K |
|
2586
Mersana Therapeutics
MRSN
$36.5M
| $72.4K | ﹤0.01% | 38,301 -287 | -0.7% | -$542 |
|
|
TPIC
2587
DELISTED
TPI Composites
TPIC
| $72.2K | ﹤0.01% | 15,875 +295 | +2% | +$1.34K |
|
2588
Solid Power
SLDP
$785M
| $72K | ﹤0.01% | 53,325 -2,106 | -4% | -$2.84K |
|
2589
Wheels Up
UP
$2.05B
| $71.6K | ﹤0.01% | 29,570 -1,012 | -3% | -$2.45K |
|
2590
Destination XL Group
DXLG
$69.4M
| $71.5K | ﹤0.01% | 24,324 +1,186 | +5% | +$3.49K |
|
|
PSTX
2591
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $71.3K | ﹤0.01% | 24,945 +318 | +1% | +$909 |
|
2592
Organogenesis Holdings
ORGO
$653M
| $71K | ﹤0.01% | 24,836 | – | – |
|
2593
Custom Truck One Source
CTOS
$1.39B
| $70.8K | ﹤0.01% | 20,531 +215 | +1% | +$742 |
|
2594
Atossa Therapeutics
ATOS
$98.5M
| $70.5K | ﹤0.01% | 46,349 | – | – |
|
2595
Cabaletta Bio
CABA
$133M
| $70.3K | ﹤0.01% | 14,904 +611 | +4% | +$2.88K |
|
2596
Monte Rosa Therapeutics
GLUE
$296M
| $69.5K | ﹤0.01% | 13,122 +1,969 | +18% | +$10.4K |
|
2597
iHeartMedia
IHRT
$320M
| $69.5K | ﹤0.01% | 37,581 +125 | +0.3% | +$231 |
|
|
NVRO
2598
DELISTED
NEVRO CORP.
NVRO
| $69.5K | ﹤0.01% | 12,433 | – | – |
|
2599
Compass Therapeutics
CMPX
$483M
| $69.3K | ﹤0.01% | 37,663 +8,974 | +31% | +$16.5K |
|
2600
TScan Therapeutics
TCRX
$102M
| $69.3K | ﹤0.01% | 13,911 +308 | +2% | +$1.53K |
|